GB201511158D0 - Cell modification and application in therapy - Google Patents
Cell modification and application in therapyInfo
- Publication number
- GB201511158D0 GB201511158D0 GBGB1511158.6A GB201511158A GB201511158D0 GB 201511158 D0 GB201511158 D0 GB 201511158D0 GB 201511158 A GB201511158 A GB 201511158A GB 201511158 D0 GB201511158 D0 GB 201511158D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapy
- application
- cell modification
- modification
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1511158.6A GB201511158D0 (en) | 2015-06-24 | 2015-06-24 | Cell modification and application in therapy |
PCT/GB2016/051881 WO2016207637A1 (en) | 2015-06-24 | 2016-06-23 | Cell modification and application in therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1511158.6A GB201511158D0 (en) | 2015-06-24 | 2015-06-24 | Cell modification and application in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201511158D0 true GB201511158D0 (en) | 2015-08-05 |
Family
ID=53784476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1511158.6A Ceased GB201511158D0 (en) | 2015-06-24 | 2015-06-24 | Cell modification and application in therapy |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201511158D0 (en) |
WO (1) | WO2016207637A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8273867B2 (en) * | 2006-02-10 | 2012-09-25 | The Regents Of The University Of California | Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS |
GB201322396D0 (en) * | 2013-12-18 | 2014-02-05 | Univ Nottingham | Transduction |
-
2015
- 2015-06-24 GB GBGB1511158.6A patent/GB201511158D0/en not_active Ceased
-
2016
- 2016-06-23 WO PCT/GB2016/051881 patent/WO2016207637A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016207637A1 (en) | 2016-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256380A1 (en) | Modified cells and methods of therapy | |
HK1250741A1 (en) | Modified gamma delta cells and uses thereof | |
IL258666A (en) | Natural killer cells and ilc3 cells and uses thereof | |
RS62047B1 (en) | Immunosuppressive agents and their use in therapy | |
GB201511382D0 (en) | Novel compounds and their use in therapy | |
GB201510758D0 (en) | Novel TNFa structure for use in therapy | |
IL259202A (en) | Modified immune cells and uses thereof | |
GB201507721D0 (en) | Immunosuppressive agents and their use in therapy | |
HUE045185T2 (en) | New therapeutic compound and use in therapy | |
GB201600747D0 (en) | Improvements in and relating to devices | |
EP3143036C0 (en) | Par-1 based therapeutic conjugates and uses thereof | |
GB201514431D0 (en) | Improvements in and relating to materials | |
GB201304038D0 (en) | Treated cells and therapeutic uses | |
GB201308753D0 (en) | Compounds and their use in therapy | |
GB201521209D0 (en) | Title and application in german | |
GB201511158D0 (en) | Cell modification and application in therapy | |
GB201506451D0 (en) | Improvements in and relating to devices | |
GB201513286D0 (en) | Improvements in and relating to construction | |
GB201506453D0 (en) | Improvements in and relating to polymer materials - I | |
GB201506463D0 (en) | Improvements in and relating to polymer materials - II | |
GB201409978D0 (en) | Novel compounds and their use in therapy | |
GB201504773D0 (en) | Methods and devices used in roofing | |
GB201502767D0 (en) | Energy reduction in buildings and transport | |
GB201423338D0 (en) | Slowing aging cell and body RNA | |
GB201411750D0 (en) | Improvements in and relating to hinges |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |